PT - JOURNAL ARTICLE AU - A Miniscalco AU - J Lundahl AU - C G Regårdh AU - B Edgar AU - U G Eriksson TI - Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. DP - 1992 Jun 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 1195--1199 VI - 261 IP - 3 4099 - http://jpet.aspetjournals.org/content/261/3/1195.short 4100 - http://jpet.aspetjournals.org/content/261/3/1195.full SO - J Pharmacol Exp Ther1992 Jun 01; 261 AB - The effects of naringenin, quercetin and kaempferol, flavonoids found in grapefruit as glycosides, on the metabolism of nifedipine and the enantiomers of felodipine were studied in microsomes from rat and human liver. Flavonoid concentrations of 10, 50 and 100 mumol/l were added to rat liver microsomes. The metabolism of nifedipine, (R)- and (S)-felodipine was inhibited to a similar extent, and the inhibition was dependent on the chemical structure and the concentration of flavonoid. Naringenin had lower inhibitory potency than quercetin and kaempferol. These flavonoids exhibited the same order of inhibitory potency in human liver microsomes. No inhibition of naringenin was found, however, until higher concentrations, 300 and 500 mumol/l, were added. A likely mechanism is inhibition of cytochrome P-450 IIIA4, the isoenzyme that catalyzes the oxidation of the dihydropyridine ring to form the corresponding pharmacologically inactive pyridine metabolite. This is a predominant metabolic step that determines the extent of first-pass extraction of dihydropyridines. Grapefruit juice has been shown recently to increase the p.o. bioavailability of the dihydropyridine calcium antagonists nifedipine and felodipine. The interaction may be explained by an inhibition of the first-pass metabolism by flavonoids in grapefruit juice. Furthermore, the results indicate that the rat may be used for in vivo studies of interactions between flavonoids and dihydropyridines or other drugs that are metabolized by cytochrome P-450 IIIA4.